Detalhe da pesquisa
1.
Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method.
Am Heart J
; 260: 124-140, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893934
2.
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation.
Am Heart J
; 266: 14-24, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567353
3.
A prediction model for asthma exacerbations after stopping asthma biologics.
Ann Allergy Asthma Immunol
; 130(3): 305-311, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509405
4.
Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.
Clin Infect Dis
; 74(1): 59-65, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704435
5.
Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 20(2): e74-e88, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33640480
6.
Asthma biologic trial eligibility and real-world outcomes in the United States.
J Asthma
; 59(12): 2352-2359, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818955
7.
Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases.
Dig Dis Sci
; 67(6): 2510-2516, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085174
8.
Characterizing Patient-Clinician Communication in Secure Medical Messages: Retrospective Study.
J Med Internet Res
; 24(1): e17273, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014964
9.
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice.
Ophthalmology
; 128(3): 417-424, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781110
10.
Optimizing Huddle Engagement Through Leadership and Problem Solving Within Primary Care: Results from a Cluster-Randomized Trial.
J Gen Intern Med
; 36(8): 2292-2299, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501530
11.
Persistence of asthma biologic use in a US claims database.
Ann Allergy Asthma Immunol
; 127(6): 648-654, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971361
12.
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation.
Clin Trials
; 18(6): 732-740, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269090
13.
Impact of High Deductible Health Plans on Diabetes Care Quality and Outcomes: Systematic Review.
Endocr Pract
; 27(11): 1156-1164, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245911
14.
Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial.
BMC Nephrol
; 22(1): 284, 2021 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419007
15.
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications.
BMC Pulm Med
; 21(1): 239, 2021 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273943
16.
Association between facility volume and mortality of patients with classic Hodgkin lymphoma.
Cancer
; 126(4): 757-764, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714588
17.
Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age.
Clin Gastroenterol Hepatol
; 18(2): 337-346.e19, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31108228
18.
ECG AI-Guided Screening for Low Ejection Fraction (EAGLE): Rationale and design of a pragmatic cluster randomized trial.
Am Heart J
; 219: 31-36, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31710842
19.
Response to Propoxyphene Market Withdrawal: Analgesic Substitutes, Doses, and Adverse Events.
Med Care
; 58(1): 4-12, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651743
20.
Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011-2016.
J Gen Intern Med
; 35(4): 1092-1101, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31792867